Main menu button

Actualités

Analysis, Annexin: Reduced visibility
07 Jan 2019
Analysis, Annexin: Reduced visibility
Equity Research
Analysis, Saniona: Obestity treatment punches its weight
19 Déc 2018
Analysis, Saniona: Obestity treatment punches its weight
Equity Research
Analysis Consilium: Turn-around on its way
14 Déc 2018
Analysis Consilium: Turn-around on its way
Equity Research
Analysis, Biovica: Targets FDA clearance in 2020
14 Déc 2018
Analysis, Biovica: Targets FDA clearance in 2020
Equity Research
Analysis TEO: Can only get better from here...
14 Déc 2018
Analysis TEO: Can only get better from here...
Equity Research
Analysis FrontOffice: Turnaround case and Fintech in focus
07 Déc 2018
Analysis FrontOffice: Turnaround case and Fintech in focus
Equity Research
Analysis Bublar: The next big game studio from Sweden?
05 Déc 2018
Analysis Bublar: The next big game studio from Sweden?
Equity Research
Analysis, Nuevolution: Early projects showing strength
04 Déc 2018
Analysis, Nuevolution: Early projects showing strength
Equity Research
Analysis, Brighter: In waiting mode
29 Nov 2018
Analysis, Brighter: In waiting mode
Equity Research
Analysis, Svenska Aerogel: According to plan
29 Nov 2018
Analysis, Svenska Aerogel: According to plan
Equity Research
Analysis, NeuroVive: Orphan drug portfolio growing up
27 Nov 2018
Analysis, NeuroVive: Orphan drug portfolio growing up
Equity Research
Analysis Mytaste Group: Strong 3rd but will Q4 be a new record?
26 Nov 2018
Analysis Mytaste Group: Strong 3rd but will Q4 be a new record?
Equity Research
Analysis Fastator: Still significant discount on NAV
23 Nov 2018
Analysis Fastator: Still significant discount on NAV
Equity Research
Analysis MaxFastigheter: Good earnings and new projects
22 Nov 2018
Analysis MaxFastigheter: Good earnings and new projects
Equity Research
Analysis Amasten: Constructing new values
21 Nov 2018
Analysis Amasten: Constructing new values
Equity Research
Analysis Precise Biometrics: Strong growth anticipated around 2020
19 Nov 2018
Analysis Precise Biometrics: Strong growth anticipated around 2020
Equity Research
Analysis Redwood Pharma: Heading towards phase II-trials
19 Nov 2018
Analysis Redwood Pharma: Heading towards phase II-trials
Equity Research
Analys Cortus: Seaching for money to finish up in Höganäs
15 Nov 2018
Analys Cortus: Seaching for money to finish up in Höganäs
Equity Research
Analysis, Follicum: Hair to stay?
15 Nov 2018
Analysis, Follicum: Hair to stay?
Equity Research
Analysis Nobina: New goals for the transportation company
15 Nov 2018
Analysis Nobina: New goals for the transportation company
Equity Research